Additionally, the peak age of melanoma patients with mutant NOTCH1 is delayed compared to those with wild-type NOTCH1, suggesting that NOTCH1 mutations may be protective against melanoma [39] These findings imply that mutant clones with cancer driver mutations might have a cancer-protective role depending on the context and timing of their mutations [3,40]. This evidence concerns the gene NOTCH1 and melanoma.